Search company, investor...

Evotec Neurosciences

evotec-neurosciences.com

Stage

Acquired | Acquired

Total Raised

$30.65M

Valuation

$0000 

About Evotec Neurosciences

Evotec Neurosciences discovers and develops therapeutics for the treatment of Alzheimer's disease and other Central Nervous System (CNS) disorders with high unmet medical needs.On March 14, 2005, Evotec Neurosciences was acquired by Evotec.52M.

Headquarters Location

Schnackenburgallee 114

Hamburg, 22525,

Germany

49 40 560 81 0

Missing: Evotec Neurosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Evotec Neurosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Evotec Neurosciences Frequently Asked Questions (FAQ)

  • Where is Evotec Neurosciences's headquarters?

    Evotec Neurosciences's headquarters is located at Schnackenburgallee 114, Hamburg.

  • What is Evotec Neurosciences's latest funding round?

    Evotec Neurosciences's latest funding round is Acquired.

  • How much did Evotec Neurosciences raise?

    Evotec Neurosciences raised a total of $30.65M.

  • Who are the investors of Evotec Neurosciences?

    Investors of Evotec Neurosciences include Evotec SE, 3i Group and TVM Capital Life Science.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.